ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Chronic inflammatory myelogenous polycystic ovary disease CIDP

Chronic inflammatory demyelinating multiple sclerosis (CIDP) is a dubious disease in the field of the nervous system, with complex clinical outcomes and often involving multi-system congestion. Early identification and standardized diagnosis are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical outcomes, imaging inspections, laboratory tests and pathological biopsies.

The platform can help to combine teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of chronic inflammatory myelogenous multiple sclerosis (CIDP) requires individualized treatment, typically including multi-dimensional management of drug therapy, rehabilitation interventions, regular follow-up, and more. In recent years, with the development of targeted therapy, immune-regulated therapy, and precision medicine, many neurological disorders that have been difficult to treat have been significantly improved.

Therapeutic efficacy and adverse reactions need to be closely monitored throughout the course of treatment and adjusted in a timely manner according to changing conditions. Multidisciplinary collaboration (MDT) is particularly important for the overall management of chronic inflammatory myelogenous multiple sclerosis (CIDP). The platform serves the China International Medical Services System, a team of national and international authorities in the field of neural systems, to provide the following services to patients: 1.

Remote pre-diagnosis: pre-examination of medical records, precise diagnostic directions and medical advice by a team of experts; 2. Interviews in China: arranging face-to-face diagnosis with authority experts, developing personalized treatment programs; 3. Full-service: one-stop services: providing medical translation, medical care, accommodation, accommodation arrangements; 4.

Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects. Support for remote pre-diagnosis, visiting interviews, full translation and escort.